FORT WAYNE, IN – BioPoly has just announced that the U.S. Food and Drug Administration (FDA) has approved an IDE clinical study for its BioPoly® RS Partial Resurfacing Knee System. The BioPoly knee is used to treat patients with painful cartilage lesions by filling...